سعر موكساكوا 0.5% محلول معقم للعين 5 مل 2022

Moxaqua 0.5% ophth. soln. 5 ml (Rameda > Medi Plus): Antibiotic (fluoroquinolone) - ophthalmic.

• Bacterial conjunctivitis caused by susceptible strains of designated organisms.Population: All ages (US label)DailyMed (U.S. National Library of Medicine)

• Ocular reactions in about 1-6%: conjunctivitis, decreased visual acuity, dry eye, keratitis, ocular discomfort, hyperaemia, pain, pruritus, subconjunctival haemorrhage, tearing. Non-ocular 1-4%: fever, cough, infection, otitis media, pharyngitis, rash, rhinitis.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• History of hypersensitivity to moxifloxacin, other quinolones or any component of the product.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Serious hypersensitivity/anaphylaxis reported with systemic quinolones; prolonged use may cause overgrowth of non-susceptible organisms including fungi; do not wear contact lenses with signs or symptoms of bacterial conjunctivitis.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• No adequate studies in pregnant women; animal studies with oral/IV moxifloxacin at clinically relevant doses showed no adverse maternal or fetal effects.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• No data on presence in human milk; systemic levels after ocular use are low. Weigh breastfeeding benefits against clinical need.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Moxifloxacin: Bactericidal; inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes needed for DNA replication, transcription, repair and recombination.